Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-paclitaxel in Metastatic Uveal Melanoma
NCT00738361Phase 2Completed
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Aug 2008
- Primary completion
- Jul 2012
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in Uveal melanoma (UM), sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Started Aug 2008; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
Uveal melanoma (UM)
Beyond the preview
Go deeper on NCT00738361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00738361.